Paul Rickey
2017
In 2017, Paul Rickey earned a total compensation of $501.7K as Senior Vice President and Chief Financial Officer at Nivalis Therapeutics.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $241,410 |
| Salary | $206,250 |
| Other | $4,000 |
| Total | $501,660 |
Rickey received $241.4K in option awards, accounting for 48% of the total pay in 2017.
Rickey also received $50K in bonus, $206.3K in salary and $4K in other compensation.
Rankings
In 2017, Paul Rickey's compensation ranked 11,860th out of 14,666 executives tracked by ExecPay. In other words, Rickey earned more than 19.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,860 out of 14,666 | 19th |
Division Manufacturing | 4,671 out of 5,772 | 19th |
Major group Chemicals And Allied Products | 1,705 out of 2,075 | 18th |
Industry group Drugs | 1,414 out of 1,731 | 18th |
Industry Pharmaceutical Preparations | 1,106 out of 1,333 | 17th |
Source: SEC filing on April 24, 2018.
Rickey's colleagues
We found five more compensation records of executives who worked with Paul Rickey at Nivalis Therapeutics in 2017.
2017
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
2017
Janice Troha
Nivalis Therapeutics
Chief Operating Officer
2017
R Carruthers
Nivalis Therapeutics
Chief Financial Officer
2017
Jon Congleton
Nivalis Therapeutics
Chief Executive Officer
2017
Stanford Peng
Nivalis Therapeutics